Literature DB >> 31219148

The Pitt Bacteremia Score Predicts Mortality in Nonbacteremic Infections.

Heather Henderson1, Courtney L Luterbach2, Eric Cober3, Sandra S Richter4, Robert A Salata5, Robert C Kalayjian6, Richard R Watkins7,8, Yohei Doi9, Keith S Kaye10, Scott Evans11, Vance G Fowler12,13, Robert A Bonomo14,15,16,17, Anthony Harris18, Sonia Napravnik1, David Van Duin1.   

Abstract

BACKGROUND: Predicting mortality risk in patients is important in research settings. The Pitt bacteremia score (PBS) is commonly used as a predictor of early mortality risk in patients with bloodstream infections (BSIs). We determined whether the PBS predicts 14-day inpatient mortality in nonbacteremia carbapenem-resistant Enterobacteriaceae (CRE) infections.
METHODS: Patients were selected from the Consortium on Resistance Against Carbapenems in Klebsiella and Other Enterobacteriaceae, a prospective, multicenter, observational study. We estimated risk ratios to analyze the predictive ability of the PBS overall and each of its components individually. We analyzed each component of the PBS in the prediction of mortality, assessed the appropriate cutoff value for the dichotomized score, and compared the predictive ability of the qPitt score to that of the PBS.
RESULTS: In a cohort of 475 patients with CRE infections, a PBS ≥4 was associated with mortality in patients with nonbacteremia infections (risk ratio [RR], 21.9; 95% confidence interval [CI], 7.0, 68.8) and with BSIs (RR, 6.0; 95% CI, 2.5, 14.4). In multivariable analysis, the hypotension, mechanical ventilation, mental status, and cardiac arrest parameters of the PBS were independent risk factors for 14-day all-cause inpatient mortality. The temperature parameter as originally calculated for the PBS was not independently associated with mortality. However, a temperature <36.0°C vs ≥36°C was independently associated with mortality. A qPitt score ≥2 had similar discrimination as a PBS ≥4 in nonbacteremia infections.
CONCLUSIONS: Here, we validated that the PBS and qPitt score can be used as reliable predictors of mortality in nonbacteremia CRE infections.
© The Author(s) 2019. Published by Oxford University Press for the Infectious Diseases Society of America. All rights reserved. For permissions, e-mail: journals.permissions@oup.com.

Entities:  

Keywords:  zzm321990 Klebsiella pneumoniaezzm321990 ; Carbapenem-resistant Enterobacteriaceae; Pitt bacteremia score; mortality; risk score

Mesh:

Substances:

Year:  2020        PMID: 31219148      PMCID: PMC7156778          DOI: 10.1093/cid/ciz528

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN: 1058-4838            Impact factor:   9.079


  35 in total

1.  Antibiotic therapy for Pseudomonas aeruginosa bacteremia: outcome correlations in a prospective study of 200 patients.

Authors:  M Hilf; V L Yu; J Sharp; J J Zuravleff; J A Korvick; R R Muder
Journal:  Am J Med       Date:  1989-11       Impact factor: 4.965

2.  Infections caused by KPC-producing Klebsiella pneumoniae: differences in therapy and mortality in a multicentre study.

Authors:  Mario Tumbarello; Enrico Maria Trecarichi; Francesco Giuseppe De Rosa; Maddalena Giannella; Daniele Roberto Giacobbe; Matteo Bassetti; Angela Raffaella Losito; Michele Bartoletti; Valerio Del Bono; Silvia Corcione; Giuseppe Maiuro; Sara Tedeschi; Luigi Celani; Chiara Simona Cardellino; Teresa Spanu; Anna Marchese; Simone Ambretti; Roberto Cauda; Claudio Viscoli; Pierluigi Viale
Journal:  J Antimicrob Chemother       Date:  2015-04-21       Impact factor: 5.790

3.  Severity of illness scoring systems in patients with bacteraemic pneumococcal pneumonia: implications for the intensive care unit care.

Authors:  C Feldman; S Alanee; V L Yu; G A Richards; A Ortqvist; J Rello; C C C Chiou; M B F Chedid; M M Wagener; K P Klugman
Journal:  Clin Microbiol Infect       Date:  2009-09       Impact factor: 8.067

4.  Surveillance of carbapenem-resistant Klebsiella pneumoniae: tracking molecular epidemiology and outcomes through a regional network.

Authors:  David van Duin; Federico Perez; Susan D Rudin; Eric Cober; Jennifer Hanrahan; Julie Ziegler; Raymond Webber; Jacqueline Fox; Pamela Mason; Sandra S Richter; Marianne Cline; Geraldine S Hall; Keith S Kaye; Michael R Jacobs; Robert C Kalayjian; Robert A Salata; Julia A Segre; Sean Conlan; Scott Evans; Vance G Fowler; Robert A Bonomo
Journal:  Antimicrob Agents Chemother       Date:  2014-05-05       Impact factor: 5.191

Review 5.  Combination antibiotic therapy versus monotherapy for gram-negative bacteraemia: a commentary.

Authors:  J W Chow; V L Yu
Journal:  Int J Antimicrob Agents       Date:  1999-01       Impact factor: 5.283

6.  Predictors of mortality in bloodstream infections caused by Klebsiella pneumoniae carbapenemase-producing K. pneumoniae: importance of combination therapy.

Authors:  Mario Tumbarello; Pierluigi Viale; Claudio Viscoli; Enrico Maria Trecarichi; Fabio Tumietto; Anna Marchese; Teresa Spanu; Simone Ambretti; Francesca Ginocchio; Francesco Cristini; Angela Raffaella Losito; Sara Tedeschi; Roberto Cauda; Matteo Bassetti
Journal:  Clin Infect Dis       Date:  2012-07-02       Impact factor: 9.079

7.  A Predictive Model of Mortality in Patients With Bloodstream Infections due to Carbapenemase-Producing Enterobacteriaceae.

Authors:  Belén Gutiérrez-Gutiérrez; Elena Salamanca; Marina de Cueto; Po-Ren Hsueh; Pierluigi Viale; José Ramón Paño-Pardo; Mario Venditti; Mario Tumbarello; George Daikos; Vicente Pintado; Yohei Doi; Felipe Francisco Tuon; Ilias Karaiskos; Isabel Machuca; Mitchell J Schwaber; Özlem Kurt Azap; Maria Souli; Emmanuel Roilides; Spyros Pournaras; Murat Akova; Federico Pérez; Joaquín Bermejo; Antonio Oliver; Manel Almela; Warren Lowman; Benito Almirante; Robert A Bonomo; Yehuda Carmeli; David L Paterson; Alvaro Pascual; Jesús Rodríguez-Baño
Journal:  Mayo Clin Proc       Date:  2016-10       Impact factor: 7.616

8.  Therapeutic approaches in patients with candidemia. Evaluation in a multicenter, prospective, observational study.

Authors:  M H Nguyen; J E Peacock; D C Tanner; A J Morris; M L Nguyen; D R Snydman; M M Wagener; V L Yu
Journal:  Arch Intern Med       Date:  1995 Dec 11-25

Review 9.  Clinical epidemiology of the global expansion of Klebsiella pneumoniae carbapenemases.

Authors:  L Silvia Munoz-Price; Laurent Poirel; Robert A Bonomo; Mitchell J Schwaber; George L Daikos; Martin Cormican; Giuseppe Cornaglia; Javier Garau; Marek Gniadkowski; Mary K Hayden; Karthikeyan Kumarasamy; David M Livermore; Juan J Maya; Patrice Nordmann; Jean B Patel; David L Paterson; Johann Pitout; Maria Virginia Villegas; Hui Wang; Neil Woodford; John P Quinn
Journal:  Lancet Infect Dis       Date:  2013-09       Impact factor: 25.071

10.  Factors influencing mortality in abdominal solid organ transplant recipients with multidrug-resistant gram-negative bacteremia.

Authors:  Bingbing Qiao; Jianzhen Wu; Qiquan Wan; Sheng Zhang; Qifa Ye
Journal:  BMC Infect Dis       Date:  2017-02-27       Impact factor: 3.090

View more
  20 in total

1.  Clinical outcomes and bacterial characteristics of carbapenem-resistant Klebsiella pneumoniae complex among patients from different global regions (CRACKLE-2): a prospective, multicentre, cohort study.

Authors:  Minggui Wang; Michelle Earley; Liang Chen; Blake M Hanson; Yunsong Yu; Zhengyin Liu; Soraya Salcedo; Eric Cober; Lanjuan Li; Souha S Kanj; Hainv Gao; Jose M Munita; Karen Ordoñez; Greg Weston; Michael J Satlin; Sandra L Valderrama-Beltrán; Kalisvar Marimuthu; Martin E Stryjewski; Lauren Komarow; Courtney Luterbach; Steve H Marshall; Susan D Rudin; Claudia Manca; David L Paterson; Jinnethe Reyes; Maria V Villegas; Scott Evans; Carol Hill; Rebekka Arias; Keri Baum; Bettina C Fries; Yohei Doi; Robin Patel; Barry N Kreiswirth; Robert A Bonomo; Henry F Chambers; Vance G Fowler; Cesar A Arias; David van Duin
Journal:  Lancet Infect Dis       Date:  2021-11-09       Impact factor: 25.071

2.  Clinical characteristics, appropriateness of empiric antibiotic therapy, and outcome of Pseudomonas aeruginosa bacteremia across multiple community hospitals.

Authors:  Keith Teelucksingh; Eric Shaw
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2021-08-30       Impact factor: 3.267

3.  Moving from predicting hospital deaths by antibiotic-resistant bloodstream bacteremia toward actionable risk reduction using machine learning on electronic health records.

Authors:  Inyoung Jun; Shannan N Rich; Simone Marini; Zheng Feng; Jiang Bian; J Glenn Morris; Mattia Prosperi
Journal:  AMIA Annu Symp Proc       Date:  2022-05-23

4.  Superinfections caused by carbapenem-resistant Enterobacterales in hospitalized patients with COVID-19: a multicentre observational study from Italy (CREVID Study).

Authors:  Marco Falcone; Lorenzo Roberto Suardi; Giusy Tiseo; Valentina Galfo; Sara Occhineri; Stefano Verdenelli; Giancarlo Ceccarelli; Melita Poli; Marco Merli; Davide Bavaro; Anna Carretta; Giuseppe Nunnari; Emmanuele Venanzi Rullo; Enrico Maria Trecarichi; Chiara Papalini; Antonina Franco; Rosa Fontana Del Vecchio; Vincenzo Bianco; Rodolfo Punzi; Daniela Francisci; Raffaella Rubino; Carlo Torti; Massimo Puoti; Sergio Carbonara; Antonio Cascio; Annalisa Saracino; Teresa Santantonio; Mario Venditti; Francesco Menichetti
Journal:  JAC Antimicrob Resist       Date:  2022-06-16

5.  Predictors of Mortality in Patients with Carbapenem-Resistant Gram-Negative Bacilli or Vancomycin-Resistant Enterococci Bacteremia.

Authors:  Hye Jin Shi; Jin Seo Lee; Yong Kyun Cho; Joong Sik Eom
Journal:  Infect Drug Resist       Date:  2020-10-09       Impact factor: 4.003

6.  Molecular and clinical epidemiology of carbapenem-resistant Enterobacterales in the USA (CRACKLE-2): a prospective cohort study.

Authors:  David van Duin; Cesar A Arias; Lauren Komarow; Liang Chen; Blake M Hanson; Gregory Weston; Eric Cober; Omai B Garner; Jesse T Jacob; Michael J Satlin; Bettina C Fries; Julia Garcia-Diaz; Yohei Doi; Sorabh Dhar; Keith S Kaye; Michelle Earley; Andrea M Hujer; Kristine M Hujer; T Nicholas Domitrovic; William C Shropshire; An Dinh; Claudia Manca; Courtney L Luterbach; Minggui Wang; David L Paterson; Ritu Banerjee; Robin Patel; Scott Evans; Carol Hill; Rebekka Arias; Henry F Chambers; Vance G Fowler; Barry N Kreiswirth; Robert A Bonomo
Journal:  Lancet Infect Dis       Date:  2020-03-06       Impact factor: 25.071

7.  Poor outcomes in both infection and colonization with carbapenem-resistant Enterobacterales.

Authors:  Jessica R Howard-Anderson; Michelle Earley; Lauren Komarow; Lilian Abbo; Deverick J Anderson; Jason C Gallagher; Matthew Grant; Angela Kim; Robert A Bonomo; David van Duin; L Silvia Muñoz-Price; Jesse T Jacob
Journal:  Infect Control Hosp Epidemiol       Date:  2022-02-02       Impact factor: 6.520

8.  Staphylococcus aureus Bacteremia in Patients Infected With COVID-19: A Case Series.

Authors:  Jaclyn A Cusumano; Amy C Dupper; Yesha Malik; Elizabeth M Gavioli; Jaspreet Banga; Ana Berbel Caban; Devika Nadkarni; Ajay Obla; Chirag V Vasa; Dana Mazo; Deena R Altman
Journal:  Open Forum Infect Dis       Date:  2020-11-12       Impact factor: 3.835

9.  Development and validation of a risk score for predicting positivity of blood cultures and mortality in patients with bacteremia and fungemia.

Authors:  Felipe Francisco Tuon; João Paulo Telles; Juliette Cieslinski; Marilia Burdini Borghi; Raquel Zanella Bertoldo; Victoria Stadler Tasca Ribeiro
Journal:  Braz J Microbiol       Date:  2021-07-21       Impact factor: 2.214

10.  Evaluation of the INCREMENT-CPE, Pitt Bacteremia and qPitt Scores in Patients with Carbapenem-Resistant Enterobacteriaceae Infections Treated with Ceftazidime-Avibactam.

Authors:  Sarah C J Jorgensen; Trang D Trinh; Evan J Zasowski; Abdalhamid M Lagnf; Sahil Bhatia; Sarah M Melvin; Samuel P Simon; Joshua R Rosenberg; Molly E Steed; Sandra J Estrada; Taylor Morrisette; Susan L Davis; Michael J Rybak
Journal:  Infect Dis Ther       Date:  2020-02-22
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.